Avoro Capital Advisors’s Fennec Pharmaceuticals FENC Stock Holding History

Avoro Capital Advisors’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,200,000	Closed	-$13.5M	–	47
2023 Q4	$13.5M	Hold	1,200,000	–	–	0.19%	39
2023 Q3	$9.01M	Hold	1,200,000	–	–	0.14%	40
2023 Q2	$10.6M	Hold	1,200,000	–	–	0.14%	39
2023 Q1	$9.98M	Hold	1,200,000	–	–	0.15%	35
2022 Q4	$11.5M	Hold	1,200,000	–	–	0.17%	35
2022 Q3	$9.72M	Hold	1,200,000	–	–	0.18%	34
2022 Q2	$6.78M	Hold	1,200,000	–	–	0.13%	37
2022 Q1	$6.72M	Hold	1,200,000	–	–	0.12%	42
2021 Q4	$5.28M	Sell	1,200,000 -470,000	-28%	-$3.5M	0.09%	40
2021 Q3	$15.7M	Hold	1,670,000	–	–	0.25%	40
2021 Q2	$12.2M	Hold	1,670,000	–	–	0.21%	39
2021 Q1	$10.4M	Hold	1,670,000	–	–	0.18%	43
2020 Q4	$12.4M	Hold	1,670,000	–	–	0.21%	37
2020 Q3	$10.1M	Hold	1,670,000	–	–	0.14%	43
2020 Q2	$13.9M	Buy	1,670,000 +564,001	+51%	+$4.19M	0.28%	39
2020 Q1	$6.57M	Hold	1,105,999	–	–	0.22%	38
2019 Q4	$7.17M	Hold	1,105,999	–	–	0.21%	28
2019 Q3	$5.32M	Hold	1,105,999	–	–	0.22%	29
2019 Q2	$4.42M	Hold	1,105,999	–	–	0.15%	31
2019 Q1	$5.36M	Hold	1,105,999	–	–	0.23%	29
2018 Q4	$7.06M	Buy	1,105,999 +83,333	+8%	+$582K	0.42%	26
2018 Q3	$8.39M	Hold	1,022,666	–	–	0.39%	32
2018 Q2	$10.7M	Buy	1,022,666 +750,000	+275%	+$8.89M	0.41%	34
2018 Q1	$3.28M	Buy	272,666 +66,666	+32%	+$630K	0.16%	44
2017 Q4	$2.73M	Buy	206,000 +139,334	+209%	+$1.39M	0.18%	39
2017 Q3	$731K	Buy	+66,666	New	+$774K	0.06%	40

Other funds holding FENC

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

SGL

Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

Avoro Capital Advisors's FENC Position: Q1 2024 in Review

Avoro Capital Advisors sold out of Fennec Pharmaceuticals (FENC) in Q1 2024, closing a stake of 1,200,000 shares — an estimated $13.5M sold.

Avoro Capital Advisors first reported a position in FENC in Q3 2017 and held it in 26 quarters. The position peaked at $15.7M in Q3 2021. 65 funds tracked by Wall St. Rank hold FENC as of Q1 2024.

Avoro Capital Advisors reported no remaining Fennec Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Avoro Capital Advisors sold 1,200,000 Fennec Pharmaceuticals shares in Q1 2024, an estimated $13.5M.
Avoro Capital Advisors first reported a position in Fennec Pharmaceuticals in Q3 2017 and held it in 26 quarters.
Avoro Capital Advisors's Fennec Pharmaceuticals position peaked at $15.7M in Q3 2021.
65 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2024.

Based on Avoro Capital Advisors's 13F filing for Q1 2024, filed 15 May 2024.